Plain-English translation of NCT07493239 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether MyCondro™, a supplement, can help improve mobility and reduce joint discomfort in people with knee osteoarthritis. Researchers want to compare two different daily doses of the medication—300 mg and 600 mg—to see which works better and how well it's tolerated. You'll take the medication at home for 12 weeks while using a smartphone app to track your symptoms and activity.
Knee osteoarthritis affects many people and limits their ability to move and stay active. This study exists to gather real-world information about whether this medication can actually help people feel better and move more easily in their daily lives.
You'll receive either a 300 mg or 600 mg dose of the medication and take two capsules by mouth each morning for 12 weeks. All activities happen at home through a smartphone app where you'll answer surveys about your pain, mobility, and how you're feeling. You'll also wear a fitness tracker to monitor your activity and complete one at-home blood test. The entire study lasts up to 20 weeks from screening to completion.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
United States